Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy

BACKGROUND: The activation of the renin-angiotensin system (RAS) promotes tumor progression. In this study, we aimed to assess whether RAS inhibitors (RASIs) could improve the outcome of hepatocellular carcinoma (HCC) patients with primary hypertension after curative liver resection. METHODS: Data o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Feng, Long-Hai, Sun, Hui-Chuan, Zhu, Xiao-Dong, Zhang, Shi-Zhe, Li, Kang-Shuai, Li, Xiao-Long, Li, Yan, Tang, Zhao-You
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990038/
https://ncbi.nlm.nih.gov/pubmed/32042755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.11.131
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars